{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2021-04-23&answer.answeringMemberPrinted=Nadhim+Zahawi&max-answer.questionFirstAnswered.=2021-04-23T13%3A45%3A10.293Z", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?answer.dateOfAnswer=2021-04-23&answer.answeringMemberPrinted=Nadhim+Zahawi&max-answer.questionFirstAnswered.=2021-04-23T13%3A45%3A10.293Z", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2021-04-23&_metadata=all&answer.answeringMemberPrinted=Nadhim+Zahawi&max-answer.questionFirstAnswered.=2021-04-23T13%3A45%3A10.293Z", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answer.dateOfAnswer=2021-04-23&answer.answeringMemberPrinted=Nadhim+Zahawi&max-answer.questionFirstAnswered.=2021-04-23T13%3A45%3A10.293Z", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2021-04-23&answer.answeringMemberPrinted=Nadhim+Zahawi&max-answer.questionFirstAnswered.=2021-04-23T13%3A45%3A10.293Z", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2021-04-23&answer.answeringMemberPrinted=Nadhim+Zahawi&max-answer.questionFirstAnswered.=2021-04-23T13%3A45%3A10.293Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1309527", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1309527/answer", "answerText" : {"_value" : "<p>The Government has invested over £300 million to secure and scale-up the UK\u2019s manufacturing capabilities to be able to respond to this pandemic, as well as any future pandemics. This includes:<\/p><p>a) Facilities that have come online:<\/p><ul><li>£65.5 million for the early manufacture of the University of Oxford/AstraZeneca vaccine;<\/li><li>£8.75 million for the set-up of the rapid deployment facility at Oxford Biomedica in Oxfordshire;<\/li><li>£8.6 million to the Centre of Process Innovation to develop GMP-ready mRNA manufacturing capability;<\/li><li>£4.7 million for skills training through the Advanced Therapies Skills Training Network, which will be delivered through both virtual and physical centres; and<\/li><li>Funding for fill and finish through a contract with Wockhardt in Wrexham, North Wales, which is currently providing fill and finish capabilities to the University of Oxford/AstraZeneca vaccine.<\/li><\/ul><p>b) Facilities that will come online later this year, to help provide longer-term UK capacity:<\/p><ul><li>£140.6 million to accelerate the completion and expanded role of the Vaccines Manufacturing Innovation Centre in Oxfordshire;<\/li><li>£127 million for the Cell and Gene Therapy Catapult in Braintree, Essex; and<\/li><li>Funding for the expansion of the Valneva factory in Livingston, Scotland.<\/li><\/ul>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
        }
        , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
        , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
        , "dateOfAnswer" : {"_value" : "2021-04-23", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-04-23T13:42:47.927Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "201"}
      , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
      , "date" : {"_value" : "2021-04-15", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Vaccination: Manufacturing Industries"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps the Department is taking to support British domestic capacity to produce future vaccines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4490", "label" : {"_value" : "Biography information for Dame Andrea Jenkyns"}
      }
      , "tablingMemberConstituency" : {"_value" : "Morley and Outwood"}
      , "tablingMemberPrinted" : [{"_value" : "Andrea Jenkyns"}
      ], "uin" : "181349"}
    , {"_about" : "http://data.parliament.uk/resources/1308939", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1308939/answer", "answerText" : {"_value" : "<p>There are no plans to do so.<\/p><p>On 13 April, the Joint Committee on Vaccination and Immunisation (JCVI) published their final advice on phase two of the COVID-19 vaccination programme, which was to continue with an age-based programme. Students planning to study abroad in the 2021-22 academic year will receive their vaccinations in line with that advice when they become eligible because of their age, individual clinical risk factors, or because they are students who work as frontline health or social care workers or are unpaid carers. In line with other adults in the United Kingdom, they can expect to receive their first dose by the end of July 2021 and their second dose within 12 weeks of their first.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
        }
        , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
        , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
        , "dateOfAnswer" : {"_value" : "2021-04-23", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-04-23T08:45:32.217Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-04-14", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "British Students Abroad: Coronavirus"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will make an announcement on the covid-19 vaccine priority applicable to students planning to study abroad in the 2021-22 academic year; and if he will make it his policy that those students will be eligible to receive both doses of that vaccine prior to the start of that academic year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4462", "label" : {"_value" : "Biography information for Tom Tugendhat"}
      }
      , "tablingMemberConstituency" : {"_value" : "Tonbridge and Malling"}
      , "tablingMemberPrinted" : [{"_value" : "Tom Tugendhat"}
      ], "uin" : "181058"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}